TOASTIE STUDY (TOLERANCE OF ANTICANCER SYSTEMIC THERAPY IN THE ELDERLY)

Project Lead: Dr Helen Dearden/Dr Mark Baxter
Current status: CLOSED to recruitment. Interim analysis expected Spring 2023

This is the NOTCH network's first prospective trainee-led study and completed recruitment in December 2022. 

​

With an ageing population we are treating an increasing number of elderly patients with chemotherapy.

Frailty is known to be associated with poor chemotherapy tolerance and increased hospital admissions. 

This prospective multi centre project aims to describe the needs of this under-represented  population, collecting data to assess validity and feasibility of using frailty scoring systems ahead of commencing chemotherapy in a NHS population. This will lead to improved patient care and could be practice changing across the UK.